加拿大安大略省非结核分枝杆菌感染相关费用(2001-2012)
该研究基于加拿大安大略省人群匹配队列,评估2001-2012年非结核分枝杆菌肺病(NTM-PD)和肺隔离(NTM-PI)的归因医疗费用。采用照护阶段法估算,NTM-PD累计1年归因费用为14,953加元(11,541美元),NTM-PI为8,729加元(6,737美元),均高于未暴露人群。
要点
- NTM-PD累计1年归因费用为14,953加元(11,541美元)。
- NTM-PI累计1年归因费用为8,729加元(6,737美元)。
- 费用最高出现在死亡前阶段,NTM-PD为1,352加元(1,044美元)。
核心结论
- NTM-PD和NTM-PI患者归因医疗费用均高于未暴露人群。
研究设计与样本
- 基于人群的匹配队列研究,利用实验室与健康行政数据链接,纳入2001-2012年安大略省NTM-PD和NTM-PI患者,匹配一般人群未暴露者。
主要发现
- 死亡前阶段费用最高:NTM-PD为1,352加元(1,044美元),NTM-PI为731加元(565美元),标准化为10天。
- NTM-PD累计平均1年归因费用为14,953加元(11,541美元)。
- NTM-PI累计平均1年归因费用为8,729加元(6,737美元)。
临床怎么用
- 临床可参考NTM-PD和NTM-PI的归因费用数据,评估疾病经济负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based matched cohort study in Ontario, Canada. We established cohorts of patients with incident NTM-PD and NTM-PI during 2001-2012 by using individually linked laboratory data and health administrative data, matched to unexposed persons from the general population. To estimate attributable costs for acute and long-term illness, we used a phase-of-care approach. Costs were stratified by age, sex, and healthcare resource, and reported in 2018 Canadian dollars (CAD) and US dollars (USD), standardized to 10 days. Costs were highest during the before-death phase (NTM-PD CAD $1,352 [USD $1,044]; NTM-PI CAD $731 [USD $565]). The cumulative mean attributable 1-year costs were CAD $14,953 (USD $11,541) for NTM-PD and CAD $8,729 (USD $6,737) for NTM-PI. Costs for patients with NTM-PD and NTM-PI were higher than those for unexposed persons.
引用
- Ramsay LC, Shing E, Wang J, et al. Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012. Emerg Infect Dis. 2020. PMID: 32818392. doi:10.3201/eid2609.190524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。